Circulating free DNA in the management of breast cancer. - Wikidata - awgldk - TriplyDB

Circulating free DNA in the management of breast cancer.

Circulating free DNA in the management of breast cancer.

http://www.wikidata.org/entity/Q34357893

about

Next-generation sequencing of circulating tumor DNA to predict recurrence in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy The number of tumorspheres cultured from peripheral blood is a predictor for presence of metastasis in patients with breast cancer.Rapid Changes in Circulating Tumor DNA in Serially Sampled Plasma During Treatment of Breast Cancer: A Case Report.Liquid Biopsies for Cancer: Coming to a Patient near You.TIPE3 protein promotes breast cancer metastasis through activating AKT and NF-κB signaling pathways.The applications of liquid biopsy in resistance surveillance of anaplastic lymphoma kinase inhibitor.Liquid Biopsy in Clinical Management of Breast, Lung, and Colorectal Cancer.Analysis of circulating tumor DNA in breast cancer as a diagnostic and prognostic biomarker.HER2 genomic amplification in circulating tumor DNA and estrogen receptor positivity predict primary resistance to trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer.

P2860

Q33866887-1DB5E372-E77B-44A1-BA72-45F0F7A336F4 Q37565410-2D2948F8-66BB-4E64-A0D5-1D357D0B2A92 Q37590179-D60BE30E-8756-4515-88B0-3BAE00CB8BEC Q37628173-6A3DCA49-D8E7-46B9-B207-138C59CA1B10 Q41472180-537208CD-0483-43E3-8E79-3CEA0EB94A5C Q47115593-C8B3623B-D076-41DC-991F-B0AE96E9E95E Q49740946-AD78297D-FF80-4DEC-B236-1B3CE37B37A7 Q52724596-796A818B-30F7-46F6-A521-31842AFC58BA Q53691004-0317E191-1AC5-453B-B678-96A5EA0E45E0

P2860

Circulating free DNA in the management of breast cancer.

http://www.wikidata.org/entity/Q34357893

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Circulating free DNA in the management of breast cancer.

@ast

Circulating free DNA in the management of breast cancer.

@en

Circulating free DNA in the management of breast cancer.

@nl

type

label

Circulating free DNA in the management of breast cancer.

@ast

Circulating free DNA in the management of breast cancer.

@en

Circulating free DNA in the management of breast cancer.

@nl

prefLabel

Circulating free DNA in the management of breast cancer.

@ast

Circulating free DNA in the management of breast cancer.

@en

Circulating free DNA in the management of breast cancer.

@nl

P1433

Q34357893-6E1462AA-EE66-4839-A5D4-107EECF903F5

P1476

Q34357893-22012AFF-CB36-4A77-BB81-11A4BFFBDF96

P2093

Q34357893-0965C0F0-02F6-49D3-B4BB-15A80F9C5486

Q34357893-6A817416-A524-4E8A-BC32-45ACD88C90A5

P2860

Q34357893-135E6C20-965F-45BD-8390-2672907D5DD6

Q34357893-1524D101-33CA-4D65-A4BF-C51E27B970BE

Q34357893-19DB9403-0996-47A3-A0BC-C27E34879785

Q34357893-273D2326-4D92-4C14-B4BD-89C688741AFA

Q34357893-35EB78AB-6C52-4FA5-99D5-FFD2A9587784

Q34357893-47E286CC-0F8B-47FF-A163-E059E7C59853

Q34357893-4D33518E-2CDB-4232-BCB5-ED354072C3BD

Q34357893-4DC923CD-185D-4127-ABCC-96F9F2600F1F

Q34357893-93E19A90-F3B5-495D-A928-8D4B66EA6755

Q34357893-99D86AA7-B275-48BE-8015-12223118251F

P304

Q34357893-C4BF496B-7304-403E-80B5-6ED6112532A9

P31

Q34357893-27f3cf5d-0ab0-451a-bbfb-6c124650efb1

Q34357893-6E81428D-EC9A-4EA8-9610-CD2C5E51A784

P356

Q34357893-845E6E2C-93D7-4809-B725-F324ECACD6E8

P433

Q34357893-1FB96FEF-B649-49D5-A520-F9272E8967B7

P478

Q34357893-4F9A9BFF-C181-48D6-85BB-57CD16DC3857

P50

Q34357893-8687121A-E168-4C53-A0B3-139F8C889472

Q34357893-CC1F23B4-EEB7-4A3A-81EF-89406F8D0684

P577

Q34357893-2B615BDB-7ED7-4697-995E-4E8AA8D7BD09

P698

Q34357893-94E680C6-5CF6-4CBB-BF7A-A28E1246C4EE

P932

Q34357893-F7959250-E185-4E9A-BA7D-86146DF5381F

P356

J.ISSN.2305-5839.2013.06.06

P1433

Annals of translational medicine

P1476

Circulating free DNA in the management of breast cancer.

@en

P2093

Jacqueline A Shaw

http://www.w3.org/2001/XMLSchema#string

Justin Stebbing

http://www.w3.org/2001/XMLSchema#string

P2860

Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer

Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing

The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers

Analysis of circulating tumor DNA to monitor metastatic breast cancer

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.

Cell-free nucleic acids as biomarkers in cancer patients.

LOH at 6q and 10q in fractionated circulating DNA of ovarian cancer patients is predictive for tumor cell spread and overall survival.

Detection of HER2 amplification in circulating free DNA in patients with breast cancer.

Circulating tumour markers can define patients with normal colons, benign polyps, and cancers.

P304

3

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3978/J.ISSN.2305-5839.2013.06.06

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Justin Stebbing

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25332979

http://www.w3.org/2001/XMLSchema#string

P932

4200656

http://www.w3.org/2001/XMLSchema#string